BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31855654)

  • 1. Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity.
    Abbasi N; Fereshtehnejad SM; Zeighami Y; Larcher KM; Postuma RB; Dagher A
    Neuroimage Clin; 2020; 25():102111. PubMed ID: 31855654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of brain structural network connection in Parkinson's disease patients with mild cognitive dysfunction: a study based on diffusion tensor imaging.
    Wang W; Mei M; Gao Y; Huang B; Qiu Y; Zhang Y; Wang L; Zhao J; Huang Z; Wang L; Nie K
    J Neurol; 2020 Apr; 267(4):933-943. PubMed ID: 31792673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
    Lee YH; Lee WJ; Chung SJ; Yoo HS; Jung JH; Baik K; Sohn YH; Seong JK; Lee PH
    J Parkinsons Dis; 2021; 11(1):239-249. PubMed ID: 33074193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease.
    Zeighami Y; Fereshtehnejad SM; Dadar M; Collins DL; Postuma RB; Dagher A
    Neuroimage Clin; 2019; 24():101986. PubMed ID: 31514113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebello-basal ganglia connectivity fingerprints related to motor/cognitive performance in Parkinson's disease.
    Kawabata K; Watanabe H; Bagarinao E; Ohdake R; Hara K; Ogura A; Masuda M; Kato T; Tsuboi T; Maesawa S; Katsuno M; Sobue G
    Parkinsonism Relat Disord; 2020 Nov; 80():21-27. PubMed ID: 32932024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Brain Connectome and Cognitive Impairment in Parkinson Disease.
    Galantucci S; Agosta F; Stefanova E; Basaia S; van den Heuvel MP; Stojković T; Canu E; Stanković I; Spica V; Copetti M; Gagliardi D; Kostić VS; Filippi M
    Radiology; 2017 May; 283(2):515-525. PubMed ID: 27924721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
    Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
    JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.
    Minett T; Su L; Mak E; Williams G; Firbank M; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn D; O'Brien JT
    J Neurol; 2018 Jul; 265(7):1528-1539. PubMed ID: 29696499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connectivity Between Brain Networks Dynamically Reflects Cognitive Status of Parkinson's Disease: A Longitudinal Study.
    Klobušiaková P; Mareček R; Fousek J; Výtvarová E; Rektorová I
    J Alzheimers Dis; 2019; 67(3):971-984. PubMed ID: 30776007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical and subcortical functional connectivity and cognitive impairment in Parkinson's disease.
    Yeager BE; Twedt HP; Bruss J; Schultz J; Narayanan NS
    Neuroimage Clin; 2024; 42():103610. PubMed ID: 38677099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease.
    Pereira JB; Aarsland D; Ginestet CE; Lebedev AV; Wahlund LO; Simmons A; Volpe G; Westman E
    Hum Brain Mapp; 2015 Aug; 36(8):2980-95. PubMed ID: 25950288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural connectome alterations in prodromal and de novo Parkinson's disease patients.
    Wen MC; Heng HSE; Hsu JL; Xu Z; Liew GM; Au WL; Chan LL; Tan LCS; Tan EK
    Parkinsonism Relat Disord; 2017 Dec; 45():21-27. PubMed ID: 28964628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study.
    Grothe MJ; Labrador-Espinosa MA; Jesús S; Macías-García D; Adarmes-Gómez A; Carrillo F; Camacho EI; Franco-Rosado P; Lora FR; Martín-Rodríguez JF; Barberá MA; Pastor P; Arroyo SE; Vila BS; Foraster AC; Martínez JR; Padilla FC; Morlans MP; Aramburu IG; Ceberio JI; Vara JH; de Fábregues-Boixar O; de Deus Fonticoba T; Pascual-Sedano B; ; Kulisevsky J; Martínez-Martín P; Santos-García D; Mir P
    Parkinsonism Relat Disord; 2021 Jul; 88():68-75. PubMed ID: 34144230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically relevant connectivity features define three subtypes of Parkinson's disease patients.
    Guo T; Guan X; Zhou C; Gao T; Wu J; Song Z; Xuan M; Gu Q; Huang P; Pu J; Zhang B; Cui F; Xia S; Xu X; Zhang M
    Hum Brain Mapp; 2020 Oct; 41(14):4077-4092. PubMed ID: 32588952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
    PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential White Matter Regional Alterations in Motor Subtypes of Early Drug-Naive Parkinson's Disease Patients.
    Wen MC; Heng HSE; Lu Z; Xu Z; Chan LL; Tan EK; Tan LCS
    Neurorehabil Neural Repair; 2018 Feb; 32(2):129-141. PubMed ID: 29347868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease.
    Jones JD; Rahmani E; Garcia E; Jacobs JP
    Parkinsonism Relat Disord; 2020 Mar; 72():7-12. PubMed ID: 32058266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.